Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2008 | Antimicrobial, dehydroascorbate reductase, and monodehydroascorbate reductase activities of defensin from sweet potato [Ipomoea batatas (L.) Lam. 'Tainong 57'] storage roots | Huang G.-J.; HSIN-CHIH LAI ; Chang Y.-S.; Sheu M.-J.; Lu T.-L.; Huang S.-S.; Lin Y.-H. | Journal of Agricultural and Food Chemistry | 35 | 29 | |
2017 | Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer | Lin V.C.; Huang S.-P.; CHAO-YUAN HUANG ; Yu C.-C.; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Lu T.-L.; Bao B.-Y. | International Journal of Medical Sciences | 7 | 8 | |
2018 | Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival | CHAO-YUAN HUANG ; Hsueh Y.-M.; Chen L.-C.; Cheng W.-C.; Yu C.-C.; Chen W.-J.; Lu T.-L.; Lan K.-J.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Medicine | 9 | 8 | |
2018 | A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer | Huang E.Y.; Chang Y.-J.; Huang S.-P.; Lin V.C.; Yu C.-C.; CHAO-YUAN HUANG ; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. | Journal of Cellular and Molecular Medicine | 14 | 16 | |
2019 | Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy | Yu C.-C.; Chen L.-C.; Lin V.C.; CHAO-YUAN HUANG ; Cheng W.-C.; Hsieh A.-R.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Medicine | 6 | 6 | |
2020 | Genetic analysis identifies the role of HLF in renal cell carcinoma | CHAO-YUAN HUANG ; HUANG S.-P.; HSUEH Y.-M.; CHEN L.-C.; LU T.-L.; BAO B.-Y. | Cancer Genomics and Proteomics | 6 | 6 | |
2020 | Genetic analysis reveals a significant contribution of ces1 to prostate cancer progression in taiwanese men | Ke C.-C.; Chen L.-C.; Yu C.-C.; Cheng W.-C.; CHAO-YUAN HUANG ; Lin V.C.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | Cancers | 8 | 9 | |
2020 | Genetic association analysis identifies a role for ANO5 in prostate cancer progression | Yu C.-C.; Chen L.-C.; CHAO-YUAN HUANG ; Lin V.C.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Medicine | 10 | 9 | |
2020 | Genetic association analysis of cell cycle regulators reveals YWHAZ has prognostic significance in prostate cancer | Yu C.-C.; Chen L.-C.; Lin W.-H.; Lin V.C.; CHAO YUAN HUANG ; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Genomics and Proteomics | 8 | 7 | |
2012 | Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; YEONG-SHIAU PU ; Hsieh C.-J.; Bao B.-Y. | Annals of Oncology | 42 | 39 | |
2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 31 | |
2021 | Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes | Tsai Y.-C.; CHAO-YUAN HUANG ; Hsueh Y.-M.; Fan Y.-C.; Fong Y.-C.; Huang S.-P.; Geng J.-H.; Chen L.-C.; Lu T.-L.; Bao B.-Y. | Life Sciences | 5 | 5 | |
2013 | Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients | Huang S.-P.; Lin V.C.; Lee Y.-C.; Yu C.-C.; CHAO-YUAN HUANG ; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Lu T.-L.; Bao B.-Y. | European Journal of Cancer | 19 | 20 | |
2019 | Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression | Yu C.-C.; Chen L.-C.; Chiou C.-Y.; Chang Y.-J.; Lin V.C.; CHAO-YUAN HUANG ; Lin I.-L.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Cell International | 15 | 13 | |
2016 | Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival | Bao B.-Y.; Lin V.C.; Yu C.-C.; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Lee H.-Z.; Pao J.-B.; CHAO-YUAN HUANG ; Huang S.-P. | Scientific Reports | 18 | 19 | |
2015 | Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer | CHAO-YUAN HUANG ; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Chiang H.-C.; Bao B.-Y. | Scientific Reports | 28 | 23 | |
2014 | Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients | Lin V.C.; CHAO-YUAN HUANG ; Lee Y.-C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | Archives of Toxicology | 12 | 11 | |
2016 | Inherited variants in Wnt pathway genes influence outcomes of prostate cancer patients receiving androgen deprivation therapy | Geng J.-H.; Lin V.C.; Yu C.-C.; CHAO-YUAN HUANG ; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Molecular Sciences | 15 | 14 | |
2021 | NRG1 genetic variant influences the efficacy of androgen-deprivation therapy in men with prostate cancer | Huang S.-P.; Chen Y.-T.; Chen L.-C.; Lee C.-H.; CHAO-YUAN HUANG ; Yu C.-C.; Lin V.C.; Lu T.-L.; Bao B.-Y. | Biomedicines | 2 | 3 | |
2011 | Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. | Clinical Cancer Research | 64 | 56 |